Cita APA (7a ed.)

R, H., AM, W., & JN, C. (2019). Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: Evidence to date. Dove Medical Press.

Cita Chicago Style (17a ed.)

R, Howell, Wright AM, y Clements JN. Clinical Potential of Liraglutide in Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: Evidence to Date. Dove Medical Press, 2019.

Cita MLA (8a ed.)

R, Howell, et al. Clinical Potential of Liraglutide in Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: Evidence to Date. Dove Medical Press, 2019.